Notch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1.

Notch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1.
复制标题

Notch-1 通过 AP-1/microRNA-451 介导的 MDR-1 调节赋予肺腺癌对紫杉烷类化学耐药性

DOI:
10.1038/mtna.2016.82
复制
发表时间:
2016-10-11
期刊:
Molecular therapy. Nucleic acids
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

我们先前已经证明Notch-1的表达与肺腺癌(LAD)患者的预后不良有关。本研究的目的是揭示Notch-1是否与紫杉烷类药物耐药的LAD相关,以及其潜在的机制。我们收集了39例接受紫杉烷类药物治疗的晚期LAD患者,发现Notch-1阳性表达与LAD的淋巴转移、复发和预后不良密切相关,多因素分析显示Notch-1是LAD预后不良的独立因素。然后,利用我们先前建立的多西紫杉醇(DTX)耐药的LAD细胞系,我们发现Notch-1在体外有助于LAD细胞对DTX的耐药,在体内抑制Notch-1使LAD对DTX增敏。我们进一步证明了Notch-1通过转录因子AP-1对miR-451的负调控部分地介导了LAD细胞的化疗耐药反应并增强了细胞的增殖能力。此外,我们发现mdr-1是miR-451的直接靶点,并影响LAD细胞的化疗耐药性。综上所述,我们的数据揭示了一个新的Notch-1/AP-1/miR-451/MDR-1信号轴,并建议了DTX与Notch抑制剂联合治疗DTX耐药LAD的新策略。
We previously demonstrated that expression of Notch-1 is associated with poor prognosis in lung adenocarcinoma (LAD) patients. The aim of this study is to reveal whether Notch-1 was associated with Taxanes-resistant LAD and, the underlying mechanisms. We collected 39 patients of advanced LAD treated with Taxanes and found that positive Notch-1 expression is closely related to LAD lymph node metastasis, recurrence and poorer prognosis, and Notch-1 acts as an independent poor prognostic factor in LAD by multivariate analysis with Cox regression model. Then, by using the Docetaxel (DTX)-resistant LAD cell lines that we established previously, we found that Notch-1 contributes to resistance of LAD cells to DTX in vitro, and inhibition of Notch-1 sensitizes LAD to DTX in vivo. We further demonstrated that Notch-1 mediates chemoresistance response and strengthens proliferation capacity in LAD cells partially through negative regulation of miR-451 by transcription factor AP-1. Moreover, we found that MDR-1 is a direct target of miR-451 and influences chemoresistance of LAD cells. Taken together, our data revealed a novel Notch-1/AP-1/miR-451/MDR-1 signaling axis, and suggested a new therapeutic strategy of combining DTX with Notch inhibitors to treat DTX-resistant LAD.
DOI: 10.3892/ijo.2013.1945
发表时间: 2013-07-01
影响因子: 5.2
作者:
Portanova, Patrizia;Notaro, Antonietta;Calvaruso, Giuseppe
通讯作者: Calvaruso, Giuseppe
DOI: 10.3892/or_00000683
发表时间: 2010-03-01
期刊: ONCOLOGY REPORTS
影响因子: 4.2
作者:
Gu, Feng;Ma, Yongjie;Fu, Li
通讯作者: Fu, Li
DOI: 10.1158/0008-5472.can-08-0969
发表时间: 2008-12-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Graziani, Irene;Eliasz, Sandra;Bocchetta, Maurizio
通讯作者: Bocchetta, Maurizio
DOI: 10.1016/j.ejca.2014.09.008
发表时间: 2014-11-01
影响因子: 8.4
作者:
Chen, Dongqin;Huang, Jiayuan;Chen, Longbang
通讯作者: Chen, Longbang
DOI: 10.1245/s10434-008-0006-z
发表时间: 2008-09-01
影响因子: 3.7
作者:
Ning, Li;Jaskula-Sztul, Renata;Chen, Herbert
通讯作者: Chen, Herbert